Our most recent publication #nuclearmedicine diagnosis of Traumatic Bronchobiliary Fistula With Late 99mTc-Mebrofenin SPECT-CT journals.lww.com/nuclearmed/Abs…

Como parte de sus tareas de cooperación, la Embajada de México en Argentina brinda apoyo en el XXIX Congreso Latinoamericano ALASBIMN 2023, con el fin de promover a Cancún, México como sede para el próximo Congreso Alasbimn Journal en 2025.

Very interesting news article in Nature, about the lack of registration of neuralink on ClinicalTrials.gov and the lack of response after a request for an interview. #nature #neuralink nature.com/articles/d4158…

First Lead-212 (Pb-212) in human images - quite remarkable that Alpha emission can be imaged with this quality. Dave Pattison AdvanCell Isotopes #PSMA jnm.snmjournals.org/content/early/…

Basal Like Breast Cancer PSMA amplification supports further studies with PSMA PET/CT #nuclearmedicine #breastcancer #psma #molecularimaging jnm.snmjournals.org/content/early/…

New #ProstateCancer risk variants identified in expanded multi-ancestry GWAS meta-analysis. Anqi Wang, PhD, MBBS Harvard T.H. Chan School of Public Health joins Andrea Miyahira Prostate Cancer Foundation to discuss findings from her study published in Nature Genetics > bit.ly/3y0DSiO

I am happy to share that Mexico will host the Latin American Congress of Nuclear Medicine and Molecular Imaging (ALASBIMN) in the beautiful city of Cancún. Save the date for ALASBIMN 2025! #nuclearmedicine #ALASBIMN #molecularimaging

OpenEvidence remains FREE for verified U.S. doctors.